{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:47:38Z","timestamp":1780537658165,"version":"3.54.1"},"reference-count":53,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1080\/14737175.2024.2405741","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T06:28:41Z","timestamp":1727159321000},"page":"1131-1140","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Intranasal zavegepant for the acute treatment of migraine"],"prefix":"10.1080","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-3035-754X","authenticated-orcid":false,"given":"Guy","family":"Greco","sequence":"first","affiliation":[{"name":"Department of Neurology, Headache Division, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8912-252X","authenticated-orcid":false,"given":"Teshamae","family":"Monteith","sequence":"additional","affiliation":[{"name":"Department of Neurology, Headache Division, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002275"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01795-2"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13588"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14153"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14232"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.12499"},{"issue":"4","key":"e_1_3_4_10_1","first-page":"23","article-title":"Update on noninvasive neuromodulation for headache treatment","volume":"23","author":"Tepper SJ","year":"2024","unstructured":"Tepper SJ, Monteith MP. Update on noninvasive neuromodulation for headache treatment. Practical Neurol (US). 2024;23(4):23\u201328.","journal-title":"Practical Neurol (US)"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01578.x"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.32.2.168"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13700"},{"issue":"1640","key":"e_1_3_4_14_1","first-page":"204","article-title":"A new dihydroergotamine nasal spray (Trudhesa) for migraine","volume":"63","year":"2021","unstructured":"A new dihydroergotamine nasal spray (Trudhesa) for migraine. Med Lett Drugs Ther. 2021;63(1640):204\u2013207.","journal-title":"Med Lett Drugs Ther"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14685"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01510.x"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneurpsyc.1938.02270040093005"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2008.01097.x"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2009.01595.x"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01546.x"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.3109\/00207454.2011.605191"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awn321"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280610"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70067-X"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00034.2013"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/30666"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230214"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705807"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410280213"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2005.00836.x"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2002.00310.x"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2004.10.001"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030505"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000286940.29755.61"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61626-8"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415584308"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01662-6"},{"key":"e_1_3_4_38_1","volume-title":"ZAVZPRET\u2122 (zavegepant) nasal spray: uS prescribing information","year":"2023","unstructured":"ZAVZPRET\u2122 (zavegepant) nasal spray: uS prescribing information. New York: Pfizer Labs; 2023."},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000203189"},{"key":"e_1_3_4_40_1","first-page":"122","article-title":"Safety, tolerability, and pharmacokinetics of single and multiple ascending doses of zavegepant nasal spray in healthy adults [abstract noP-142]","volume":"62","author":"Bertz R","year":"2022","unstructured":"Bertz R, Madonia DM, Madonia J et al. Safety, tolerability, and pharmacokinetics of single and multiple ascending doses of zavegepant nasal spray in healthy adults [abstract noP-142]. Headache. 2022;62:122.","journal-title":"Headache"},{"key":"e_1_3_4_41_1","volume-title":"Zavegepant","author":"Drugs and Lactation Database (LactMed\u00ae) [Internet]","year":"2006","unstructured":"Drugs and Lactation Database (LactMed\u00ae) [Internet]. Zavegepant. Bethesda (MD): National Institute of Child Health and Human Development; 2006. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK591127\/"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241252666"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14389"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00517-8"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13140"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000202067"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14051"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813049"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.16711"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811090"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31606-X"},{"key":"e_1_3_4_52_1","unstructured":"Lipton R Conway C Stock E et al. Efficacy safety and tolerability of rimegepant 75 mg an oral CGRP receptor antagonist for the acute treatment of migraine: results from a double-blind randomized placebo-controlled trial study 301. Headache. 2018."},{"key":"e_1_3_4_53_1","unstructured":"Prescribing information: nURTEC ODT- Rimegepant sulfate tablet orally disintegrating. [cited 2024 Apr 4]. Available from: https:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=19036"},{"key":"e_1_3_4_54_1","unstructured":"Prescribing information: uBRELVY\u00ae (Ubrogepant) tablets for oral use. [cited 2023 Apr 4]. Available from: https:\/\/www.rxabbvie.com\/pdf\/ubrelvy_pi.pdf"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01683-5"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737175.2024.2405741","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T07:27:04Z","timestamp":1733470024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737175.2024.2405741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1080\/14737175.2024.2405741"],"URL":"https:\/\/doi.org\/10.1080\/14737175.2024.2405741","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iern20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}